Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Takhzyro loss of exclusivity?When did the saxenda patent expire in the eu?Nuzyra synthesis route patents?In what ways does iron alter lipitor's impact on nutrient absorption?Odefsey generic name?
See the DrugPatentWatch profile for keytruda
Keytruda’s FDA approval for melanoma was in 2014.
Keytruda (pembrolizumab) received FDA approval in 2014 for unresectable or metastatic melanoma (with treatment context tied to prior therapy at the time of approval).
Other Questions About Keytruda :